Resmed (RMD) Gross Profit (2009 - 2026)

Resmed (RMD) has 18 years of Gross Profit data on file, last reported at $891.0 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 16.25% year-over-year to $891.0 million; the trailing twelve-month figure through Mar 2026 stood at $3.4 billion (up 15.6% YoY), and the FY2025 full-year result was $3.1 billion, up 15.05% from the prior year.
• Gross Profit for Q1 2026 stood at $891.0 million, up from $878.7 million in the prior quarter.
• Across five years, Gross Profit topped out at $891.0 million in Q1 2026 and bottomed at $491.2 million in Q1 2022.
• The 5-year median for Gross Profit is $692.8 million (2024), against an average of $686.5 million.
• The widest annual swing landed in 2022, when Gross Profit rose 6.48%; it then climbed 25.76% in 2023.
• A 5-year view of Gross Profit shows it stood at $579.7 million in 2022, then grew by 11.6% to $646.9 million in 2023, then advanced by 16.13% to $751.3 million in 2024, then increased by 16.96% to $878.7 million in 2025, then advanced by 1.39% to $891.0 million in 2026.
• The last three Gross Profit figures came in at $891.0 million (Q1 2026), $878.7 million (Q4 2025), and $820.8 million (Q3 2025), per Business Quant data.

Peer Comparison